GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
49.72
+0.72 (1.47%)
At close: Jun 3, 2026, 4:00 PM EDT
50.77
+1.05 (2.11%)
Pre-market: Jun 4, 2026, 8:39 AM EDT
GSK Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,780 | 32,667 | 31,376 | 30,328 | 29,324 | 24,696 | |
Revenue Growth (YoY) | 3.97% | 4.12% | 3.46% | 3.42% | 18.74% | 1.40% |
Cost of Revenue | 8,955 | 9,017 | 9,048 | 8,565 | 9,554 | 8,163 |
Gross Profit | 23,825 | 23,650 | 22,328 | 21,763 | 19,770 | 16,533 |
Selling, General & Admin | 9,137 | 9,088 | 11,015 | 9,385 | 8,372 | 7,070 |
Research & Development | 7,755 | 7,525 | 6,401 | 6,223 | 5,488 | 5,019 |
Other Operating Expenses | -1,076 | -895 | 891 | -590 | -523 | 87 |
Total Operating Expenses | 15,816 | 15,718 | 18,307 | 15,018 | 13,337 | 12,176 |
Operating Income | 8,009 | 7,932 | 4,021 | 6,745 | 6,433 | 4,357 |
Interest Income | 137 | 169 | 122 | 115 | 76 | 14 |
Interest Expense | -706 | -701 | -669 | -792 | -879 | -769 |
Other Non-Operating Income (Expense) | -3 | 1 | 3 | -4 | -2 | -3 |
Total Non-Operating Income (Expense) | -572 | -531 | -544 | -681 | -805 | -758 |
Pretax Income | 7,437 | 7,401 | 3,477 | 6,064 | 5,628 | 3,599 |
Provision for Income Taxes | 1,081 | 1,112 | 526 | 756 | 707 | 83 |
Net Income | 5,829 | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Minority Interest in Earnings | 527 | 573 | 376 | 380 | 665 | 711 |
Earnings From Discontinued Operations | - | - | - | - | 10,700 | 1,580 |
Net Income to Common | 5,829 | 5,716 | 2,575 | 4,928 | 14,956 | 4,385 |
Net Income Growth | 84.87% | 121.98% | -47.75% | -67.05% | 241.07% | -23.73% |
Shares Outstanding (Basic) | 2,017 | 2,026 | 2,039 | 2,026 | 2,013 | 2,002 |
Shares Outstanding (Diluted) | 2,047 | 2,059 | 2,071 | 2,056 | 2,042 | 2,026 |
Shares Change (YoY) | -1.05% | -0.60% | 0.75% | 0.66% | 0.79% | 0.55% |
EPS (Basic) | 2.89 | 2.82 | 1.26 | 2.43 | 7.43 | 2.19 |
EPS (Diluted) | 2.85 | 2.78 | 1.24 | 2.40 | 7.32 | 2.16 |
EPS Growth | 86.39% | 123.15% | -48.12% | -67.26% | 238.45% | -24.12% |
Shares Outstanding | 2,010 | 2,006 | 2,041 | 2,028 | 2,156 | 2,155 |
Free Cash Flow | 6,376 | 6,393 | 5,155 | 5,454 | 6,260 | 7,002 |
Free Cash Flow Growth | -0.27% | 24.02% | -5.48% | -12.88% | -10.60% | -6.04% |
Free Cash Flow Per Share | 3.12 | 3.11 | 2.49 | 2.65 | 3.07 | 3.46 |
Dividends Per Share | 0.670 | 0.660 | 0.610 | 0.580 | 0.613 | 1.000 |
Dividend Growth | 1.52% | 8.20% | 5.17% | -5.31% | -38.75% | - |
Gross Margin | 72.68% | 72.40% | 71.16% | 71.76% | 67.42% | 66.95% |
Operating Margin | 24.43% | 24.28% | 12.82% | 22.24% | 21.94% | 17.64% |
Profit Margin | 19.39% | 19.25% | 9.41% | 17.50% | 16.78% | 14.24% |
FCF Margin | 19.45% | 19.57% | 16.43% | 17.98% | 21.35% | 28.35% |
EBITDA | 8,009 | 10,246 | 6,572 | 9,039 | 8,580 | 6,479 |
EBITDA Margin | 24.43% | 31.36% | 20.95% | 29.80% | 29.26% | 26.24% |
EBIT | 8,009 | 7,932 | 4,021 | 6,745 | 6,433 | 4,357 |
EBIT Margin | 24.43% | 24.28% | 12.82% | 22.24% | 21.94% | 17.64% |
Effective Tax Rate | 14.54% | 15.02% | 15.13% | 12.47% | 12.56% | 2.31% |